Bridging the Healing Gap: A Single-Blind Clinical Trial Assessing the Efficacy of Carboxy-gel in Reducing Bruising and Pain Post-Liposuction
Launched by TOTAL DEFINER RESEARCH GROUP · Jan 19, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Bridging the Healing Gap," is exploring whether a treatment called CO2 Lift can help reduce bruising and pain after liposuction surgery. Researchers want to know if using CO2 Lift leads to less bruising by the seventh day after surgery compared to a placebo treatment (which is just Vaseline) and how it affects patients' pain levels and overall satisfaction with their recovery.
To participate in this study, adults aged 18 to 65 who are scheduled for liposuction (with or without other procedures) may be eligible. However, those who are pregnant, have severe skin issues, or significant health problems won’t qualify. Participants will receive CO2 Lift on one side of their body and Vaseline on the other after surgery, and their recovery will be monitored through photos and pain assessments over the following week. This trial is currently recruiting participants who are looking for ways to enhance their recovery experience after liposuction.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing body contouring procedures (liposuction or liposculpture), either individually or combined with a maximum of two other major aesthetic procedures involving face, breast, or dermo-lipectomy.
- • healthy patients without underlying comorbidities (classified as ASA≤II)
- Exclusion Criteria:
- • Pregnant patients
- • Known allergy to CO2 Lift or Vaseline
- • History of keloid formation or significant dermatological conditions.
- • Coagulopathy or current use of anticoagulant therapy.
- • Skin disorders related to collagen disease.
- • BMI ≥ 32 kg/m2.
About Total Definer Research Group
Total Definer Research Group is a leading clinical trial sponsor dedicated to advancing medical research and improving patient care through innovative study designs and rigorous methodologies. With a focus on collaboration and transparency, the organization partners with healthcare professionals, institutions, and regulatory bodies to conduct high-quality clinical trials across various therapeutic areas. The group's commitment to ethical practices and patient safety ensures that their research not only meets regulatory standards but also contributes valuable insights to the medical community, ultimately enhancing treatment options and outcomes for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bogota, Dc, Colombia
Sao Paulo, , Brazil
Cuidad De Mexico, Df, Mexico
Mexico City, Df, Mexico
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported